COVID-19 ASSOCIATED REDUCTION IN HYPERTENSION-RELATED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN EXCELLENCE CENTERS OF THE EUROPEAN SOCIETY OF HYPERTENSION

被引：0
|
作者：
Weber, Thomas [1 ]
Kreutz, Reinhold [2 ]
Januszewicz, Andrzej [3 ]
Mayer, Christopher [4 ]
Tsioufis, Konstantinos [5 ]
Abraham, Gyorgy [6 ]
Amar, Jaques [7 ]
Barna, Istvan [8 ]
Sebba Barroso, Weimer Kunz [9 ]
De Backer, Tine [10 ]
van der Giet, Marcus [2 ]
机构：
[1] Klinikum Wels Grieskirchen, Cardiol Dept, Wels, Austria
[2] Charite, Hypertens Ctr Berlin, Berlin, Germany
[3] Inst Cardiol, Dept Hypertens, Warsaw, Poland
[4] Austrian Inst Technol, Vienna, Austria
[5] Natl & Kapodistrian Univ Athens, Cardiol Clin 1, Athens, Greece
[6] Hypertens Ctr, Nephrol, Dept Med 1, Szeged, Hungary
[7] Toulouse Univ Hosp, Toulouse, France
[8] Semmelweis Univ, Fac Med, Dept Internal Med 1, Budapest, Hungary
[9] Univ Fed Goias, Hypertens League, Goiania, Go, Brazil
[10] Univ Hosp Gent, Heymans Inst Clin Pharmacol, Cardiovasc Ctr, Ghent, Belgium
来源：
JOURNAL OF HYPERTENSION | 2022年 / 40卷 / SUPPL期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E28 / E28
页数：1
相关论文
共 50 条
  • [31] Genetic screening for hypertension and COVID-19 reveals functional variation of SPEG potentially associated with severe COVID-19 in women
    Luo, Yu-Si
    Shen, Xiang-Chun
    Li, Wei
    Wu, Guo-Feng
    Yang, Xiao-Meng
    Guo, Ming-Yang
    Chen, Fang
    Shen, Hu-Yan
    Zhang, Ping-Ping
    Gao, Han
    Nie, Ying
    Wu, Jia-Hong
    Mou, Rong
    Zhang, Ke
    Cheng, Zhong-Shan
    FRONTIERS IN GENETICS, 2023, 13
  • [32] Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients
    Barrera, Francisco J.
    Shekhar, Skand
    Wurth, Rachel
    Moreno-Pena, Pablo J.
    Ponce, Oscar J.
    Hajdenberg, Michelle
    Alvarez-Villalobos, Neri A.
    Hall, Janet E.
    Schiffrin, Ernesto L.
    Eisenhofer, Graeme
    Porter, Forbes
    Brito, Juan P.
    Bornstein, Stefan R.
    Stratakis, Constantine A.
    Gonzalez-Gonzalez, Jose Gerardo
    Rodiguez-Gutierrez, Rene
    Hannah-Shmouni, Fady
    JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (09)
  • [33] Non-hypertension-associated Posterior Reversible Encephalopathy Syndrome in COVID-19
    Sharma, Dhruva
    Tomar, Deeksha S.
    Gupta, Sachin
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (05) : 639 - 640
  • [34] Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19
    Zhen-Mu Jin
    Ji-Chan Shi
    Mo Zheng
    Que-Lu Chen
    Yue-Ying Zhou
    Fang Cheng
    Jing Cai
    Xian-Gao Jiang
    World Journal of Clinical Cases, 2022, (01) : 128 - 135
  • [35] Sildenafil for treatment of associated pulmonary hypertension in patients with severe COVID-19 pneumonia
    Qamar, Irfan
    May, James
    Anwar, Asad
    Bascon, Nordita
    Crerar-Gilbert, Agnieszka
    Madden, Brendan
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [36] Serum triglyceride level and hypertension are highly associated with the recovery of COVID-19 patients
    Wang, Liping
    Zhang, Yifa
    Cheng, Yanbo
    Li, Chunyang
    Wang, Yongxiang
    Yan, Xuebing
    Xu, Xingshun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (10): : 6646 - 6654
  • [37] Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19
    Jin, Zhen-Mu
    Shi, Ji-Chan
    Zheng, Mo
    Chen, Que-Lu
    Zhou, Yue-Ying
    Cheng, Fang
    Cai, Jing
    Jiang, Xian-Gao
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (01) : 128 - 135
  • [38] HYPERTENSION AND RISK FACTORS ASSOCIATED WITH IN-HOSPITAL DEATH IN PATIENTS WITH COVID-19
    Elamin, Maha Ismail
    Hassan, Dina Ahmed
    Bashir, Intisar Abdelrahim
    Mahmoud, Tarig E.
    JOURNAL OF HYPERTENSION, 2023, 41 : E232 - E233
  • [39] Diagnostic and therapeutic recommendations for the Thrombotic Immune Response Associated to COVID-19 (RITAC)
    Esteban Gauna, Mauricio
    Luis Bernava, Juan
    CORSALUD, 2020, 12 (01): : 60 - 63
  • [40] A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension
    Itoh, Hiroshi
    HYPERTENSION RESEARCH, 2020, 43 (09) : 857 - 858
12345